Skip to content

Assessment of Novaloc and Locator Attachment Systems

Mechanical and Biological Assessment of Two Different Attachment Materials in Maxillary Implant Retained Overdenture In-Vivo Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06011031
Enrollment
14
Registered
2023-08-25
Start date
2021-06-05
Completion date
2024-12-05
Last updated
2024-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Completely Edentulous Maxilla

Keywords

implant overdenture, maxilla, novaloc, locator, peek

Brief summary

The aim of the current study is to assess the effect of two types of attachments (Locator, Novaloc) on the supporting structures both mechanically using stress strain analysis and biologically through measuring bone height using cbct.

Detailed description

14 Completely edentulous patients will be divided into two groups each group contains seven patients: Group One: Each patient will be restored with 4 implant retained maxillary overdenture using Peek retention inserts attachment system and Bone Level Ti-Zr implants. Group Two: Each patient will be restored with 4 implant retained maxillary overdenture using Nylon retention insert attachment system and Bone Level Ti implants. Bone height in millimeters will then be evaluated around each implant using cone beam computed tomography at the time of placement of attachments, 6 months, 1 year

Interventions

Each patient will be restored with 4 implants retained maxillary overdenture with the assigned attachment

Each patient will be restored with 4 implants retained maxillary overdenture with the assigned attachment

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Masking description

all selected patients were restored with a complete denture prosthesis and then wer devided using random allocation software into 2 groups

Intervention model description

This is a Randomized Clinical Trial (phase IV) as it will compare two types of attachment systems (a new one with an old one), assess the effects of both types, and state which one is better.

Eligibility

Sex/Gender
ALL
Age
30 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Completely edentulous patient with u shaped dental arch. * Systemically free. * Patients completed all extraction at least 6 months before surgery. * Patients Tempromandibular joint is free from any disease. * Patient's mouth opening is proper for accessibility during surgery and implant placement. * Sufficient bone level (length, and width) at implant placement site. * Presence of enough bone height at implant site close to the maxillary sinus. * Absence of sinus pneumatization.

Exclusion criteria

* Heavy smoker. * Patients with bone diseases. * Patients having a history of parafunctional habits. * Patients with diabetes mellitus. * Patients on chemotherapy or radiotherapy. * Patients on any medications that reduce wound healing. * Patients without sufficient bone level (height, width). * Patients with sinus pneumatization.

Design outcomes

Primary

MeasureTime frameDescription
bone level change around implantsThrough study completion an average 1 year.measurement of bone height mesial, distal to each implant

Secondary

MeasureTime frameDescription
patient satisfactionThrough study completion an average 1 year.Patient satisfaction was evaluated using a questionnaire based on the visual analog scale (VAS). Patients were asked to mark their answers (amount of satisfaction). The questionnaire was given to the patients in Arabic.Six factors were rated on a 1 to 5 scale (highly satisfied = 5; satisfied = 4; fair = 3; dissatisfied = 2; highly dissatisfied = 1). The sum of the five sub-scores was then calculated, ranging from 5 to 30 (best score = 30, worst score = 5). The low range of scores indicated low satisfaction.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026